Fundraising Fox
Phimed Europe
1 known investors
Find your way into Phimed Europe
Sign up to see every warm intro you have to Phimed Europe
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Phimed Europe team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Phi Med Europe develops NerveCheck, a portable medical device for early diagnosis and quantification of peripheral neuropathy, particularly diabetic neuropathy, using quantitative sensory testing (QST) technology. The device delivers rapid, non-invasive assessment of small and medium nerve fiber function for healthcare professionals in clinical settings.
Investors · 1
Frequently asked questions
- What does Phimed Europe do?
- Phi Med Europe develops NerveCheck, a portable medical device for early diagnosis and quantification of peripheral neuropathy, particularly diabetic neuropathy, using quantitative sensory testing (QST) technology. The device delivers rapid, non-invasive assessment of small and medium nerve fiber function for healthcare professionals in clinical settings.
- Who are Phimed Europe's investors?
- Phimed Europe's investors include Ship2B.